Mohs Micrographic Surgery in Skin of Color

Ramone Williams, David Ciocon

Research output: Contribution to journalReview articlepeer-review

Abstract

The United States population is becoming increasingly diverse. Data show increased utilization of Mohs micrographic surgery (MMS) in people of color. Though the incidence of skin cancer in skin of color is low, morbidity and mortality are disproportionately high. Still, published literature on the topic is lacking. In this article, we outline our approach to MMS in skin of color. We review salient topics not published elsewhere in literature in this context, including post-operative postinflammatory hyperpigmentation and suture selection in skin of color. Our goal is to better equip dermatologic surgeons for the rapidly changing demographics of our patient population. We feel this is an important step in addressing the dire health disparities associated with skin cancer in skin of color. J Drugs Dermatol. 2022;21(5):536-541. doi:10.36849/JDD.6469.

Original languageEnglish (US)
Pages (from-to)536-541
Number of pages6
JournalJournal of drugs in dermatology : JDD
Volume21
Issue number5
DOIs
StatePublished - May 1 2022

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Mohs Micrographic Surgery in Skin of Color'. Together they form a unique fingerprint.

Cite this